Who owns Protalix BioTherapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of PLX from SEC Form 13F filings across 107 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 107 institutions disclosed 15.9M shares of Protalix BioTherapeutics, Inc. worth $43.8M — about 19.7% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
107
13F holders
$43.8M
value, 2026 filers
19.7%
of shares outstanding (15.9M sh)
19
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of PLX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 4.2M | $11.6M | 0.0% | 5.2% | +3.8% |
| 2 | STATE STREET CORP | 1.2M | $3.2M | 0.0% | 1.4% | +17.6% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 997,128 | $2.8M | 0.0% | 1.2% | +1.7% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 988,100 | $2.7M | 0.0% | 1.2% | -9.8% |
| 5 | GOLDMAN SACHS GROUP INC | 889,350 | $2.5M | 0.0% | 1.1% | +86.9% |
| 6 | NORTHERN TRUST CORP | 831,726 | $2.3M | 0.0% | 1% | -9.8% |
| 7 | DIMENSIONAL FUND ADVISORS LP | 716,986 | $2.0M | 0.0% | 0.9% | +45.3% |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLC | 557,199 | $1.5M | 0.0% | 0.7% | +9.1% |
| 9 | Stratos Wealth Partners, LTD. | 400,000 | $1.1M | 0.0% | 0.5% | -20.0% |
| 10 | Creative PlanningNEW | 375,359 | $1.0M | 0.0% | 0.5% | new |
| 11 | STRS OHIO | 332,500 | $917,700 | 0.0% | 0.4% | +12.3% |
| 12 | ACADIAN ASSET MANAGEMENT LLCNEW | 331,946 | $913,000 | 0.0% | 0.4% | new |
| 13 | MARSHALL WACE, LLP | 301,768 | $832,880 | 0.0% | 0.4% | -33.3% |
| 14 | CITADEL ADVISORS LLC | 281,229 | $776,192 | 0.0% | 0.3% | -15.9% |
| 15 | LAZARD ASSET MANAGEMENT LLC | 269,900 | $744,924 | 0.0% | 0.3% | +63.0% |
| 16 | Russell Investments Group, Ltd. | 248,557 | $686,016 | 0.0% | 0.3% | +903.7% |
| 17 | Bank of New York Mellon Corp | 231,814 | $639,807 | 0.0% | 0.3% | -0.5% |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 194,228 | $536,069 | 0.0% | 0.2% | +7.7% |
| 19 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIPNEW | 163,881 | $452,312 | 0.0% | 0.2% | new |
| 20 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 157,444 | $434,545 | 0.0% | 0.2% | -16.7% |
| 21 | Concurrent Investment Advisors, LLCNEW | 126,314 | $348,627 | 0.0% | 0.2% | new |
| 22 | BANK OF AMERICA CORP /DE/ | 115,339 | $318,336 | 0.0% | 0.1% | +122.3% |
| 23 | Nuveen, LLC | 98,593 | $272,117 | 0.0% | 0.1% | +9.3% |
| 24 | Empowered Funds, LLCNEW | 98,344 | $271,429 | 0.0% | 0.1% | new |
| 25 | MORGAN STANLEY | 97,585 | $269,334 | 0.0% | 0.1% | +88.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.